Quick Answer
OCTAVE SPECIALTY GROUP INC reported Cash and Equivalents of $17.00 million for fiscal year 2021.
OCTAVE SPECIALTY GROUP INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $17.00M | -15.0% |
| 2020 | $20.00M | -16.7% |
| 2019 | $24.00M | -61.9% |
| 2018 | $63.00M | -89.9% |
| 2017 | $624.00M | +585.5% |
| 2016 | $91.03M | +107.6% |
| 2012 | $43.84M | +174.0% |
| 2011 | $16.00M | +68.5% |
| 2010 | $9.50M | -91.5% |
| 2009 | $112.08M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $29.00M | +107.1% | -9.4% |
| June 30, 2022 | $32.00M | +146.2% | -46.7% |
| March 31, 2022 | $60.00M | +160.9% | +252.9% |
| December 31, 2021 | $17.00M | -15.0% | +21.4% |
| September 30, 2021 | $14.00M | -62.2% | +7.7% |
| June 30, 2021 | $13.00M | -23.5% | -43.5% |
| March 31, 2021 | $23.00M | -60.3% | +15.0% |
| December 31, 2020 | $20.00M | -16.7% | -45.9% |
- OCTAVE SPECIALTY GROUP INC showed a decrease of -15.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2021 period, OCTAVE SPECIALTY GROUP INC’s cash and equivalents has declined by 84.8% (from $112.08 million to $17.00 million).
- The most recent figure is from OCTAVE SPECIALTY GROUP INC’s fiscal year 2021 report (Form 10-K), filed with the SEC on February 24, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: